
|Articles|August 1, 1998
The American Journal of Managed Care
- August 1998
- Volume 4
- Issue 8
Treatment Options for Prostate Cancer: Part 2 -- Early and Late Stage and Hormone Refractory Disease
Author(s)LTC Judd W. Moul, MD, MC, USA
Advertisement
Articles in this issue
about 27 years ago
Identification and Assessment of High-Risk Seniorsabout 27 years ago
Outpatient Antidepressant Utilization in a Dutch Sick Fundabout 27 years ago
Inborn Errors of Metabolism: Medical and Administrative "Orphans"about 27 years ago
Generic Drug Product Equivalence: Current StatusNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
2
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
3
Efgartigimod Outperforms Standard IVIG in Averting Myasthenic Crisis
4
CAR T-Cell Therapy Holds Potential in SCLC, but Significant Barriers Remain
5